CASP3 and urea cycle disorder: Indeed, treatment of AECs with 4-phenylbutyrate (4-PBA), a FDA-approved drug for the treatment of urea cycle disorder used as a chemical chaperone improving protein misfolding21, markedly prevented the hypoxia-induced increase in caspase 3 activity and Bim expression.